Stay updated on Avelumab Combo Regimens in R/R DLBCL Clinical Trial
Sign up to get notified when there's something new on the Avelumab Combo Regimens in R/R DLBCL Clinical Trial page.

Latest updates to the Avelumab Combo Regimens in R/R DLBCL Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study record now shows termination of the trial with closure of arms due to futility and enrollment challenges, citing evolving treatment landscape as the rationale.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedCore content updated to reflect government funding status and a new version (v3.2.0) with added lymphoma resource; previous version (v3.1.0) removed.SummaryDifference2%

- Check46 days agoChange DetectedPage update: version bumped to v3.1.0 with removal of the 'Diffuse large B-cell lymphoma' topic from the resources.SummaryDifference0.3%

- Check60 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1), and the Back to Top element has been removed.SummaryDifference0.1%

- Check67 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check74 days agoChange DetectedThe web page has been updated to include new drug information and additional locations for a study, while some previous locations and drug information have been removed. Notably, the facility name and specific locations in Belgium and Poland have been added.SummaryDifference8%

Stay in the know with updates to Avelumab Combo Regimens in R/R DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Combo Regimens in R/R DLBCL Clinical Trial page.